Killing the sick instead of treating them, why didn’t we ever think of that? One reason is our evil for-profit health care system actually sees sick people as a profit source. While a socialized health care system looks at sick people and sees an extended financial drain.

“Couldn’t we just save a lot of money, by killing them quickly?” Why yes, says the Canadian Medical Association. We certainly could.

New research suggests medically assisted dying could result in substantial savings across Canada’s health-care system.

What’s a human life worth?

Doctor-assisted death could reduce annual health-care spending across the country by between $34.7 million and $136.8 million, according to a report published in the Canadian Medical Association Journal on Monday.

The savings exceedingly outweigh the estimated $1.5 to $14.8 million in direct costs associated with implementing medically assisted dying.

$35 million? Now you’re talking real money. 

“Socialized medicine: we kill the sick and pass the savings on directly to you.”

How much would it take to get you to kill someone? The Canadian Medical Association’s got the answer. 

“The take-away point is that there may be some upfront costs associated with offering medical assisted dying to Canadians, but there may also be a reduction in spending elsewhere in the system and therefore offering medical assistance in dying to Canadians will not cost the health care system anything extra,” said Aaron Trachtenberg, an author of the report and a resident in internal medicine at the University of Calgary.

The takeaway is that if Dr. Trachtenberg is your doctor… run. 

“It’s just the reality of working in a system of finite resources.”

That’s socialized medicine in a nutshell. Instead of expanding resources, it contracts them and practices endless triage. Who has to live and die? How much money can we save by offing Larry so we can free up more cash for Bob’s transgender surgery to turn him into Betty.

The report also emphasized that it is only a cost analysis and doesn’t include the clinical effects on patients. Patient-level research will need to be done before true economic evaluation of medical assistance in dying in terms of cost-effectiveness and utility can be done, the report said.

If you find any patient-level research being done on you, know that it’s for the greater good.